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Background: A new concept of risk stratification for patients with aortic stenosis, based upon age combined with a fixed number of predefined 
risk factors, was proposed during the design of SURTAVI trial. The purpose of this study was to compare the SURTAVI model with surgical risk scores 
i.e. logistic EuroSCORE (LES), EuroSCORE II (ES II) and STS score in patients selected by the “Heart Team” for TAVI after formal surgical turn down.
methods: Eighty eight consecutive patients underwent TAVI via trans-femoral, trans-apical and other approaches. LES, ES II and STS score were 
calculated retrospectively. Patients were classified into low (≥70yrs and <2 risk factors, ≥75yrs and no risk factor), intermediate (≥70yrs and 2-3 risk 
factors, ≥75yrs and 1-2 risk factors, ≥80yrs and ≤1 risk factor) and high risk (≥70yrs and >3 risk factors, ≥75yrs and >2 risk factors, ≥80yrs and >1 
risk factor) groups according to SURTAVI model and surgical risk scores (LES <10, 10 - 20, >20%, ES II <4, 4 -10, >10% and STS <4, 4 -10, >10% 
respectively) and actual 30-day and 1-year mortality was compared.
results: are summarised in the table below.
Table: Actual 30-day and 1-year mortality (%) according to risk groups. 
30- day mortality
Groups LES ESII STS-score SURTAVI model
Low Risk 8.33 5.88 10.00 16.66
Intermediate Risk 11.43 11.11 8.16 11.11
High Risk 4.88 5.71 5.26 6.25
p - Value 0.562 0.875 1.0 0.376
1-year mortality
Low Risk 25.00 23.53 10.00 16.66
Intermediate Risk 22.86 19.44 30.61 11.11
High Risk 26.83 31.43 26.32 29.68
p - Value 0.943 0.502 0.203 0.254
conclusion: SURTAVI model was no better than other risk scores in predicting mortality, both at 30 days and 1 year, in patients undergoing 
TAVI after formal surgical turn down. This highlights deficiencies of the proposed SURTAVI risk model and thus emphasises on the role of a 
multidisciplinary “Heart Team” in risk assessment.
